Edition:
India

Celgene Corp (CELG.OQ)

CELG.OQ on NASDAQ Stock Exchange Global Select Market

78.80USD
22 Jun 2018
Change (% chg)

$-0.34 (-0.43%)
Prev Close
$79.14
Open
$79.30
Day's High
$79.88
Day's Low
$78.72
Volume
2,231,341
Avg. Vol
2,436,237
52-wk High
$147.13
52-wk Low
$74.14

Chart for

About

Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology... (more)

Overall

Beta: 1.88
Market Cap(Mil.): $108,911.00
Shares Outstanding(Mil.): 782.35
Dividend: --
Yield (%): --

Financials

  CELG.OQ Industry Sector
P/E (TTM): 43.29 30.95 32.74
EPS (TTM): 3.22 -- --
ROI: 10.08 14.84 14.38
ROE: 37.19 16.34 16.08

BUZZ-India's Panacea Biotec rises on settlement deal with Celgene

** Shares of Panacea Biotec Ltd rise as much as 5.2 pct to 287.2 rupees - highest since June 12

18 Jun 2018

CORRECTED-UPDATE 2-Celgene tops estimates on higher demand for cancer drug Revlimid

* To resubmit ozanimod marketing application earlier than expected

04 May 2018

BRIEF-Celgene Reports Q1 Adjusted Earnings Per Share Of $2.05

* CELGENE REPORTS FIRST QUARTER 2018 OPERATING AND FINANCIAL RESULTS

04 May 2018

Celgene's quarterly profit dips 9 percent

May 4 Celgene Corp's quarterly profit fell about 9 percent despite the U.S. biotech reporting higher revenue, as its expenses surged.

04 May 2018

BRIEF-Celgene Corp Entered Into An Amended And Restated Credit Agreement

* CELGENE CORP - ENTERED INTO AN AMENDED AND RESTATED CREDIT AGREEMENT TO EXTEND TERM OF CREDIT FACILITY TO APRIL 25, 2023 FROM APRIL 17, 2022 Source text (https://bit.ly/2HCsgr2) Further company coverage:

01 May 2018

Wall St slides as healthcare drags but manages monthly gain

NEW YORK Wall Street fell on Monday as healthcare stocks slid and investors worried about rising costs for companies as oil prices rose, although the major indexes eked out a gain in April to snap a two-month losing streak. | Video

01 May 2018

Wall Street slides as healthcare drags but manages monthly gain

NEW YORK Wall Street fell on Monday as healthcare stocks slid and investors worried about rising costs for companies as oil prices rose, although the major indexes eked out a gain in April to snap a two-month losing streak. | Video

01 May 2018

BRIEF-Celgene Corp Says CEO Mark Alles's FY 2017 Total Compensation Was $13.1 Mln Vs $12.2 Mln In FY 2016

* CELGENE CORP SAYS CEO MARK ALLES'S FY 2017 TOTAL COMPENSATION WAS $13.1 MILLION VERSUS $12.2 MILLION IN FY 2016 - SEC FILING

30 Apr 2018

BRIEF-Zymeworks And Celgene Expand Bispecific Antibody Collaboration

* ZYMEWORKS AND CELGENE EXPAND BISPECIFIC ANTIBODY COLLABORATION

24 Apr 2018

BRIEF-Celgene Announces Changes To Its Board Of Directors

* CELGENE CORPORATION ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS

19 Apr 2018

Competitors

  Price Chg
Takeda Pharmaceutical Co Ltd (4502.T) ¥4,468 -26.00
Eisai Co., Ltd (4523.T) ¥7,995 -85.00
Johnson & Johnson (JNJ.N) $122.84 +1.39
Novartis AG (NOVN.S) CHF75.60 +0.10
Pfizer Inc. (PFE.N) $36.51 +0.21
Roche Holding Ltd. (ROG.S) CHF216.45 --
Roche Holding Ltd. (RO.S) CHF223.60 +4.00
Merck & Co., Inc. (MRK.N) $61.47 +0.29
Sanofi SA (SASY.PA) €69.01 +1.30
AstraZeneca plc (AZN.L) 5,229.00 -26.00

Earnings vs. Estimates